The Uromigos

GU Oncology Now

<p>Dr. Jeannie Hoffman-Censits discusses her randomized phase 2 trial on adding sacituzumab govitecan to maintenance avelumab in metastatic urothelial cancer.</p>


Episode 421: ASCO 2025 - Maintenance Avelumab +/- SG in Advanced Bladder Cancer

Dr. Jeannie Hoffman-Censits discusses her randomized phase 2 trial on adding sacituzumab govitecan to maintenance avelumab in metastatic urothelial cancer.

The Uromigos Episode 421: ASCO 2025 - Maintenance Avelumab +/- SG in Advanced Bladder Cancer

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtables

Uromigos Live 2024

Localized

mHSPC/mCSPC

CRPC

Diagnostics

Prostate Cancer

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Renal Cell Carcinoma

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

Advancements in Oncology

The Oncology Brothers

Expert Interviews

Journal

Subscribe

Regional Roundtables

Episode 421: ASCO 2025 - Maintenance Avelumab +/- SG in Advanced Bladder Cancer

Related Podcasts